1. Home
  2. AERT vs UNCY Comparison

AERT vs UNCY Comparison

Compare AERT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • UNCY
  • Stock Information
  • Founded
  • AERT 2012
  • UNCY 2016
  • Country
  • AERT Singapore
  • UNCY United States
  • Employees
  • AERT N/A
  • UNCY N/A
  • Industry
  • AERT Professional Services
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • AERT Consumer Discretionary
  • UNCY Health Care
  • Exchange
  • AERT Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • AERT 33.6M
  • UNCY 31.9M
  • IPO Year
  • AERT N/A
  • UNCY 2021
  • Fundamental
  • Price
  • AERT $0.59
  • UNCY $0.66
  • Analyst Decision
  • AERT
  • UNCY Strong Buy
  • Analyst Count
  • AERT 0
  • UNCY 4
  • Target Price
  • AERT N/A
  • UNCY $5.50
  • AVG Volume (30 Days)
  • AERT 33.9K
  • UNCY 1.5M
  • Earning Date
  • AERT 11-19-2024
  • UNCY 11-13-2024
  • Dividend Yield
  • AERT N/A
  • UNCY N/A
  • EPS Growth
  • AERT N/A
  • UNCY N/A
  • EPS
  • AERT N/A
  • UNCY N/A
  • Revenue
  • AERT $72,141,000.00
  • UNCY N/A
  • Revenue This Year
  • AERT N/A
  • UNCY N/A
  • Revenue Next Year
  • AERT N/A
  • UNCY N/A
  • P/E Ratio
  • AERT N/A
  • UNCY N/A
  • Revenue Growth
  • AERT 16.98
  • UNCY N/A
  • 52 Week Low
  • AERT $0.59
  • UNCY $0.20
  • 52 Week High
  • AERT $3.12
  • UNCY $1.82
  • Technical
  • Relative Strength Index (RSI)
  • AERT 22.83
  • UNCY 52.04
  • Support Level
  • AERT $0.59
  • UNCY $0.62
  • Resistance Level
  • AERT $0.91
  • UNCY $0.87
  • Average True Range (ATR)
  • AERT 0.10
  • UNCY 0.08
  • MACD
  • AERT 0.00
  • UNCY -0.01
  • Stochastic Oscillator
  • AERT 4.49
  • UNCY 15.45

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Share on Social Networks: